Literature DB >> 25861509

Surgical resection for a second primary lung cancer originating close to the initial surgical margin for lung squamous cell carcinoma.

Seijiro Sato1, Terumoto Koike1, Takehisa Hashimoto1, Masanori Tsuchida1.   

Abstract

Few reports have described surgical resection for second primary lung cancers originating close to the initial surgical margin for lung cancer. A 64-year-old man had undergone left segmentectomy with lymph node dissection for small peripheral squamous cell lung cancer using video-assisted thoracic surgery, with pathology confirming a small tumor 12 mm in diameter identified about 3 cm from the surgical margin. Eighteen months after initial surgery, computed tomography revealed a 30 mm pulmonary nodule close to the initial surgical margin in the residual left upper lobe and the serum level of carcinoembryonic antigen was found to be increased. Local recurrence on the staple-line of the surgical margin was suspected, and completion left upper lobectomy was performed. Histological examination identified not only a squamous cell carcinoma component but also a small cell carcinoma component. The immunohistochemical staining pattern of the second tumor differed from that of the initial resected lung squamous cell carcinoma. The final pathological diagnosis was a second primary tumor with mixed small cell carcinoma and squamous cell carcinoma histology.

Entities:  

Year:  2015        PMID: 25861509      PMCID: PMC4377375          DOI: 10.1155/2015/462193

Source DB:  PubMed          Journal:  Case Rep Surg


1. Introduction

In recent times, small peripheral malignant lung tumor has increasingly been treated by limited resection using video-assisted thoracic surgery (VATS) to minimize the volume of lung resected and the size of the thoracotomy incision [1]. Staplers have routinely been used and various complications of the surgical margins have been reported [2-4] with this increasing use. A new lesion originating close to the initial surgical margin during postoperative follow-up is one such complication. Principal differential diagnoses for such lesions include local recurrence of the initial lung malignancy, nontuberculous mycobacterial infection or fungal infection caused by nonanatomical stapling, and foreign-body granuloma. However, in addition to these diseases, the possibility of a second primary lung cancer should be considered. To the best of our knowledge, only one previous report [5] has described a second primary lung cancer originating close to the initial surgical margin. We report herein a case of a second primary lung cancer originating close to the initial surgical margin for a previous lung squamous cell carcinoma and treated by surgical segmentectomy.

2. Case Presentation

A 64-year-old man underwent segmentectomy with lymph node dissection for lung cancer of left segments 1 + 2 in March 2012. Pathologically, the tumor was diagnosed as a moderately differentiated squamous cell carcinoma, measuring 12 × 8 mm (pT1aN0M0). Immunohistochemical staining showed positive expression of CK5/6 and p63 and negative expression of thyroid transcription factor 1 (TTF-1), CD56, chromogranin A (CGA), and synaptophysin. The tumor was about 3 cm from the surgical margin and no residual cancer cells were identified (Figure 1). In October 2013, serum levels of carcinoembryonic antigen (CEA) were found to be elevated. Computed tomography (CT) revealed a 30 mm pulmonary nodule close to the initial surgical margin (Figure 2). Positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) showed uptake by the tumor, but no region of uptake other than the equivocal uptake area. In November 2013, the patient was admitted on suspicion of local recurrence along the staple-line of the surgical margin. He had a 44-year history of smoking 1 pack/day until 2 years earlier. Physical examination yielded normal results. Laboratory data showed that the serum level of CEA was 12.1 ng/mL (normal, <4.3 ng/mL), and pro-gastrin-releasing peptide (ProGRP) level was 134 pg/mL (normal, <81 pg/mL). Pulmonary function testing showed normal result. Reoperation was performed, with intraoperative rapid diagnosis suggesting squamous cell carcinoma, and completion left upper lobectomy was performed.
Figure 1

The tumor (arrow) measuring 13 mm is about 3 cm away from the surgical margin (arrowhead).

Figure 2

Chest CT reveals a 30 mm pulmonary nodule close to the initial surgical margin (arrowhead).

Macroscopically, the tumor was a solid, whitish mass measuring 32 × 25 mm and showing partial necrosis. Histological examination identified a main small cell carcinoma component with a high nuclear-cytoplasmic ratio, unclear nucleoli, and fine chromatin (Figure 3(a)) and a smaller squamous cell carcinoma component (Figure 3(b)). Immunohistochemically, tumor cells of the small cell carcinoma component showed positive staining for thyroid transcription factor 1 (TTF-1), chromogranin A (CGA), synaptophysin, and CD56 (Figure 3(c)) but negative staining for p63 and CK5/6 (Figure 3(d)). By contrast, cells of squamous cell carcinoma component were positive for p63 and CK5/6 (Figure 3(d)) but negative for TTF-1, CGA, synaptophysin, and CD56 (Figure 3(c)). The staining pattern of the second tumor differed from that of the squamous cell carcinoma resected from the lung previously. For these reasons, pathological diagnosis was a second primary combining small cell lung carcinoma and squamous cell carcinoma and intrapulmonary lymph node metastasis (pT2aN1M0). The postoperative course was uneventful, and the patient received chemotherapy for small cell lung cancer.
Figure 3

Histopathological examination shows that the tumor comprises a main small cell carcinoma component (a) and a smaller squamous cell carcinoma component (b). Immunohistochemically, tumor cells of the small cell carcinoma component show positive staining for CD56 (c) but negative staining for CK5/6 (d). By contrast, cells of squamous cell carcinoma component were positive for CK5/6 (d) but negative for CD56 (c).

3. Discussion

Reports of lung tumors close to the initial surgical margin of a resected lung cancer resection are gradually increasing as reduction surgeries and staplers for dissection of the intersegmental plane see greater use. One differential diagnosis is surgical-margin recurrence after lung cancer resection. Another is an infectious mass occurring after ventilatory impairment and blood flow obstruction in the lung tissue from stapling result in the development of an infection from pathogens that were present preoperatively [3]. A third possibility is foreign-body granuloma, a noninfectious mass resulting from a foreign-body (antigen) response activating T-cells and macrophages that cause epithelioid cells and giant cells to emerge [5]. In making a differential diagnosis from imaging, CT often reveals a noncancerous lesion with a linear margin, calcification, diffuse shadows, and no involvement of blood vessels and bronchial tubes [6, 7]. Recent reports have indicated that fluorodeoxyglucose- (FDG-) PET is not particularly informative, with a diagnostic sensitivity for malignancy of 63%, specificity of 56%, and a proper diagnosis rate of 60% for nodes ≤30 mm and a threshold maximum standardized uptake value (SUVmax) of 2.5 [8]. Including the present report, 13 cases of lung masses close to the initial surgical margin have been reported in Japan (Table 1) [2–5, 9–16]. However, many represented nontuberculous mycobacteria or foreign-body granuloma. Diagnosis was obtained in only one [5] of the five cases in which preoperative diagnosis was attempted, indicating that preoperative diagnosis is very difficult. Only four patients underwent PET-CT preoperatively, and the SUVmax for the infectious mass [3] was high, at 4.59, suggesting difficulty in using this approach to identify malignancy. Only two of the 13 patients were diagnosed with a second primary lung cancer, and multiple primary lung cancers are extremely rare.
Table 1

Reports of new nodules originating close to the initial surgical margin in Japan.

AuthorTanaka et al. [9]Tomita et al. [2]Kono et al. [10]Katsura et al. [4]Furukawa et al. [11]Matsuoka et al. [12]Ohtsuka et al. [13]Murakami et al. [3]Matsuoka et al. [14]Tempaku et al. [15]Motono et al. [16]Kitahara et al. [5]Our patient

Year2003200320052005200720072008200920112012201220132015

Age50746076576269726059647766

SexFMMFFFFFMFMMM

Initial surgical procedureSegmentectomyWedgeSegmentectomyWedgeSegmentectomyLobectomy + segmentectomyWedgeLobectomyWedgeWedgeWedgeWedgeSegmentectomy

PET-CTN/AN/AN/AN/AN/AN/AN/ASUVmax 4.59SUVmax 1SUVmax 1.9N/AN/AStrong accumulation

Preoperative diagnosisFBS: negativeN/AFBS: negativeN/AFBS: negativeCTNB: negativeN/AN/AN/AN/AN/AFBS: adenocarcinomaN/A

Pathology of secondary nodulePulmonary tuberculosisPulmonary foreign body granulomaMycobacterial granulomaPulmonary suture granuloma with Aspergillus Mycobacterial granulomaMycobacterial granulomaPulmonary foreign body granulomaMycobacterial granulomaLocal recurrencePulmonary foreign body granulomaPulmonary foreign body granulomaSecond primary lung cancerSecond primary lung cancer

Disease-free interval60 m24 m28 m24 m48 m51 m57 m96 m56 m60 m7 m72 m18m

F: female; M: male; N/A: not available; FBS: fiber bronchoscopy; CTNB: CT-guided needle lung biopsy.

At present, the adequacy of segmentectomy for lung cancers ≤2 cm with radiologically pure solid lesion remains controversial. The results of ongoing prospective randomized trials of lobar versus sublobar resection in patients with small peripheral non-small-cell lung cancers, such as JCOG 0802/WJOG 4607L [17], are eagerly awaited. We performed segmentectomy for the lung cancer ≤2 cm with pure solid component at initial surgery, because no involvement of hilar lymph nodes was evident intraoperatively. In the present case, there were several reasons why we diagnosed the tumor as a second primary lung cancer rather than local recurrence along the staple-line of the surgical margin. First, from the perspective of the histological findings, including immunohistochemical staining, the lung cancer specimen from the initial surgery differed from the second primary specimen. The pathological diagnosis was squamous cell lung cancer in the initial surgery, compared to combined small cell lung cancer and squamous cell lung cancer in the second surgery. Second, a few reports [18, 19] have described cases in which EGFR-mutant non-small-cell lung carcinoma has acquired resistance to EGFR-TKI therapy through transformation to small cell lung cancer. However, the patient in this case had not received any postoperative treatment for cancer, including molecular targeted therapy, and local recurrence of the initial squamous cell carcinoma with transformation to small cell lung cancer was deemed highly unlikely. Third, the second primary tumor was about 3 cm from the initial resection stump.

4. Conclusion

Cases of new nodule originating close to the initial surgical margin seem to have increased in frequency, possibly because selected limited resection and the use of staplers for dissection of the intersegmental plane have increased. In addition to local recurrence, infectious nodules, and foreign-body granuloma, the possibility of a second primary lung cancer should be considered in such cases.
  12 in total

1.  Pulmonary granuloma possibly caused by staples after video-assisted thoracoscopic surgery.

Authors:  Masaki Tomita; Yasunori Matsuzaki; Masao Edagawa; Tetsuya Shimizu; Masaki Hara; Toshio Onitsuka
Journal:  Ann Thorac Cardiovasc Surg       Date:  2003-04       Impact factor: 1.520

2.  [Small size lung adenocarcinoma with rocal recurrence and port site recurrence 56 months after partial resection].

Authors:  Hisashi Matsuoka; Takanori Miyoshi; Masami Morimoto; Naoki Hino; Masaru Tsuyuguchi
Journal:  Kyobu Geka       Date:  2011-12

Review 3.  [Pulmonary suture granuloma with Aspergillus after partial resection for lung cancer; report of a case].

Authors:  Hiroshi Katsura; K Iuchi; A Matsumura
Journal:  Kyobu Geka       Date:  2005-02

4.  Comparison of quantitatively analyzed dynamic area-detector CT using various mathematic methods with FDG PET/CT in management of solitary pulmonary nodules.

Authors:  Yoshiharu Ohno; Mizuho Nishio; Hisanobu Koyama; Yasuko Fujisawa; Takeshi Yoshikawa; Sumiaki Matsumoto; Kazuro Sugimura
Journal:  AJR Am J Roentgenol       Date:  2013-06       Impact factor: 3.959

5.  Thoracic and cardiovascular surgery in Japan during 2011: Annual report by The Japanese Association for Thoracic Surgery.

Authors:  Jun Amano; Hiroyuki Kuwano; Hiroyasu Yokomise
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-10

6.  A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).

Authors:  Kenichi Nakamura; Hisashi Saji; Ryu Nakajima; Morihito Okada; Hisao Asamura; Taro Shibata; Shinichiro Nakamura; Hirohito Tada; Masahiro Tsuboi
Journal:  Jpn J Clin Oncol       Date:  2009-11-22       Impact factor: 3.019

Review 7.  [Non-tuberculous mycobacterial infection along the staple-suture line after segmentectomy for small peripheral lung cancer; report of a case].

Authors:  Yoshihiko Kono; S Endo; S Otani; N Saito; T Hasegawa; Y Sato; Y Sohara
Journal:  Kyobu Geka       Date:  2005-02

8.  [Surgical treatment for 2nd primary lung cancer originated close to the initial surgical margin for bronchioloalveolar carcinoma (BAC); report of a case].

Authors:  Akihiko Kitahara; Tadashi Aoki; Masatomo Yazawa
Journal:  Kyobu Geka       Date:  2013-02

9.  The diagnostic accuracy of a solitary pulmonary nodule, using thin-section high resolution CT: a solitary pulmonary nodule by HRCT.

Authors:  N Takanashi; Y Nobe; H Asoh; T Yano; Y Ichinose
Journal:  Lung Cancer       Date:  1995-10       Impact factor: 5.705

10.  Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation.

Authors:  Ryotaro Morinaga; Isamu Okamoto; Kazuyuki Furuta; Yukiko Kawano; Masaru Sekijima; Kensaku Dote; Takao Satou; Kazuto Nishio; Masahiro Fukuoka; Kazuhiko Nakagawa
Journal:  Lung Cancer       Date:  2007-06-29       Impact factor: 5.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.